Trials / Conditions / Cancer of Unknown Origin
Cancer of Unknown Origin
3 registered clinical trials studyying Cancer of Unknown Origin.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin. NCT03628079 | Repos Pharma | Phase 1 / Phase 2 |
| Completed | Genomic Testing and Resulting Medical Decisions NCT03301493 | Arbeitsgemeinschaft medikamentoese Tumortherapie | — |
| Completed | Engagement of Patients With Advanced Cancer NCT02966509 | Stanford University | N/A |